In this study we evaluated the expression of LFA-1, VLA-4 and L-selectin antigens on circulating T cells and serum levels of soluble vWF, ICAM-1, VCAM-1 and P-selectin in patients with SSc with associated PAH, at baseline and after 12 months of bosentan therapy, as compared to patients with SSc without PAH and healthy subjects. This evidence concerns the gene SELL and systemic sclerosis.